@ARTICLE{
author={Budimkic Maja S,Valcic Vanja,Pekmezovic Tatjana D,Mesaros Sarlota T,Tamas Olivera S,Veselinovic Nikola D,Momcilovic Nikola,Vitkovic Jelena,Andabaka Marko M,Jankovic Mladen,Ristic Dusan,Veljancic Nevena,Martinovic Vanja N,Jeremic Marta,Drulovic Jelena S},
year={2025},
title={Real world data of cladribine effectiveness: Data from MS Belgrade treatment cohort with up to 5 year follow-up},
journal={MULTIPLE SCLEROSIS JOURNAL},
volume={31},
number={3},
pages={1254-1254},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Ristic Dusan,Budimkic Maja S,Vitkovic Jelena,Tamas Olivera S,Veselinovic Nikola D,Momcilovic Nikola,Veljancic Nevena,Valcic Vanja,Mesaros Sarlota T,Pekmezovic Tatjana D,Drulovic Jelena S},
year={2025},
title={Safety profile of siponimod in patients with secondary progressive multiple sclerosis: A retrospective real-world analysis},
journal={MULTIPLE SCLEROSIS JOURNAL},
volume={31},
number={3},
pages={1182-1182},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Valcic Vanja,Radoicic Damjana,Veselinovic Nikola D,Momcilovic Nikola,Tamas Olivera S,Andabaka Marko M,Ivanovic Jovana B,Vitkovic Jelena,Drulovic Jelena S,Mesaros Sarlota T,Pekmezovic Tatjana D,Veljancic Nevena,Ristic Dusan,Budimkic Maja S},
year={2025},
title={Paroxysmal symptoms in Neuromyelitis Optica spectrum disorder},
journal={MULTIPLE SCLEROSIS JOURNAL},
volume={31},
number={3},
pages={790-791},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Tamas Olivera S,Bresliev Aleksandar,Valcic Vanja,Kovacevic Marija,Veselinovic Nikola D,Budimkic Maja S,Jovicevic Vanja,Momcilovic Nikola,Andabaka Marko M,Vitkovic Jelena,Mesaros Sarlota T,Drulovic Jelena S},
year={2024},
title={Pseudobulbar Affect in Multiple Sclerosis},
journal={MULTIPLE SCLEROSIS JOURNAL},
volume={30},
number={3},
pages={746-746},
document_type={Meeting Abstract},
}